Vivos Therapeutics Inc (VVOS) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Vivos Therapeutics Inc   (NASDAQ: VVOS)


Vivos Therapeutics Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Vivos Therapeutics Inc 's ROA in the second quarter of 2026?
Vivos Therapeutics Inc recorded a cumulative net loss of $-26 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -102.53%.

However, within the Healthcare sector 745 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 4258, from total ROA ranking in the first quarter of 2026 at 4937.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Total Assets Change -7.26 % 121.97 % 48.01 % 80.36 % 78 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -26 -25 -21 -17 -14
Return On Assets (TTM) -102.53 % -98.62 % -96.38 % -85.57 % -83.59 %
VVOS's Total Ranking # 4258 # 4937 # 4338 # 4370 # 4403
Total Assets (TTM) in million 24 25 25 26 26
Seq. Total Assets Change -3.59 % -0.43 % -1.92 % -1.49 % 130.75 %
Seq. Net Income Change - - - - -

VVOS's 5 Years Annual ROA >> Back to VVOS Management Effectiveness >> Compare VVOS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 173
Sector # 746
Overall # 4232

Return On Assets Statistics
High Average Low
58.25 %
-68.17 %
-134.27 %
(Sep 30 2022)   (Mar 31 2024)



  News about Vivos Therapeutics Inc Return on Assets ROA

Vivos Therapeutics Pioneering the Future of Obstructive Sleep Apnea Treatment with CPT Coverage, Medicare Reimburse...

In a pivotal advancement for the treatment of obstructive sleep apnea (OSA), Vivos Therapeutics has been granted new Current Procedural Terminology (CPT) coverage and reimbursement codes by the American Medical Association for its flagship Vivos CARE oral medical devices. This development is expected to significantly streamline the billing process for commercial payers, ultimately enhancing accessibility to effective treatment options for both adults and children suffering from OSA.The implementation of these new medical codes marks a critical milestone in addressing the growing healthcare challenges associated with OSA, a condition that affects millions globally. Historically, patients have faced substantial hurdles in obtaining insurance reimbursement for oral appliance therapies, which are essential alternatives to traditional continuous positive airway pressure (CPAP) devices. However, with the recent CPT code designations, Vivos CARE treatment is positioned to become a viable and reimbursable option within the healthcare framework.



Financial Statements
Vivos Therapeutics Inc 's Assets $ 24 million VVOS's Balance sheet
Vivos Therapeutics Inc 's Income $ -6 million Quarterly VVOS's Income Statement
VVOS's Income by Division See VVOS's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 47.25 % 52.51 % -22.29 % -64.31 % 31.52 %
Total Assets in million 21 14 9 12 34
Y / Y Net Income Change - - - - -
Net Income in million -21 -11 -14 -24 -20
Annual Return On Assets -101.16 % -78.14 % -145.35 % -198.3 % -60.22 %

VVOS's 5 Years Annual ROA >> Back to VVOS Management Effectiveness >> Compare VVOS ROA to its Competitors



More Return On Assets Ratios
VVOS's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
VVOS's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for VVOS's Competitors
Subscribers only: Roa for Vivos Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for VVOS's Customers

You may also want to know
VVOS's Roi VVOS's Inventory Turnover Ratio VVOS's Growth Rates VVOS's Dividend Comparisons
VVOS's Profitability Ratios VVOS's Asset Turnover Ratio VVOS's Dividend Growth
VVOS's Roe VVOS's Valuation Ratios VVOS's Financial Strength Ratios VVOS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-09-12T06:25:24+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.